Navigation Links
Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
Date:2/24/2011

ients with advanced kidney cancer. Nexavar inhibits both the tumor cell and tumor vasculature. In preclinical studies, Nexavar has been shown to inhibit members of two classes of kinases thought to be involved in both cell proliferation (growth) and angiogenesis (blood supply) – two important processes that enable cancer growth. These kinases included Raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET.

Nexavar is currently approved in 100 countries.

Nexavar is also being evaluated by the companies, international study groups, government agencies and individual investigators.

Important Safety Considerations For Patients Taking Nexavar

NEXAVAR in combination with carboplatin and paclitaxel is contraindicated in patients with squamous cell lung cancer. Nexavar may cause fetal harm when administered to a pregnant woman. Women of childbearing potential are advised to avoid becoming pregnant and female patients should also be advised against breast-feeding while receiving Nexavar.

Cardiac ischemia and/or myocardial infarction may occur. Temporary or permanent discontinuation of Nexavar should be considered in patients who develop cardiac ischemia and/or myocardial infarction. Gastrointestinal perforation was an uncommon adverse reaction and has been reported in less than 1% of patients taking Nexavar.

Uncommon but serious adverse reactions including keratoacanthomas/squamous cell cancer of the skin and Stevens - Johnson Syndrome have been reported in clinical trials.

An increased risk of bleeding may occur following Nexavar administration. If bleeding necessitates medical intervention, consider discontinuation of Nexavar. Hypertension may occur early in the course of treatment. Monitor blood pressure weekly during the first 6 weeks and periodically thereafter and treat, as required.

Hand-foot skin reaction and rash are common and management may include topical therapies for symptomatic re
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Wash. , May 22, 2015  BioLife Solutions, Inc. ... of proprietary clinical grade hypothermic storage and ... for cells and tissues ("BioLife" or the "Company"), announced ... Marcum MicroCap Conference. The Company is scheduled ... Wednesday, May 27, 2015 at the Grand Hyatt Hotel in ...
(Date:5/22/2015)... 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a ... and regeneration, today announced that J.J. Finkelstein , ... a corporate overview at two upcoming investor conferences. ... 4 th Annual Microcap Conference on Thursday May ... at 11:00 am EDT.  A webcast will be ...
(Date:5/22/2015)... According to a new market ... Instruments, Services), by Test Type (Indirect, Enzyme-based, Reactive Oxygen ... End Users - Global Forecast to 2020", published by ... reach $736.85 Million by 2020 from $452.36 Million in ... Browse 71 market data Tables and 90 Figures ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... LOS ANGELES, Sept. 15, 2011 Trig Medical, ... progression management and interventional ultrasound guidance, today announced its participation ... Gynecology,s (ISUOG) 21st World Congress on Ultrasound in ... Regency Century Plaza in Los Angeles. In addition to exhibiting ...
... 2011 Transcript Pharmacy lands on the Inc. 5000 ... the fourth year in a row and is ranked 116 in ... trusted by so many health care professionals and so many patients ... needs," said Cliff Osbon, president of Transcript Pharmacy. "We are successful ...
Cached Medicine Technology:Trig Medical Presents Innovative Labor Progression Management System at ISUOG 21st World Congress 2Trig Medical Presents Innovative Labor Progression Management System at ISUOG 21st World Congress 3Mississippi Pharmacy Recognized on Inc. 5000 List 2
(Date:5/23/2015)... Phoenix, AZ (PRWEB) May 23, 2015 Manufacturers ... Heating Seasonal Performance Factor (HSPF) of 8.2. Experts in the ... will ultimately benefit consumers. , The HSPF score is what ... score the more efficient the unit. Although the minimum HSPF ... for water heaters with an HSPF score north of 12. ...
(Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Rehabilitation Center, 557 N. Washington St., Janesville, will host ... 5:30-6:30 pm. , The 8-week clinic is lead by ... BSN, who will offer training that encompasses a warm-up, ... and show selection and weekly training plans. , The ...
(Date:5/23/2015)... Baltimore, MD (PRWEB) May 23, 2015 Injury ... moratorium that has been passed by the Maryland legislature but ... , “The Maryland General Assembly passed HB 449 ... the Governor has not signed it into law. This bill ... 2017. Evidence is growing that demonstrates the danger of fracking ...
(Date:5/22/2015)... OR (PRWEB) May 22, 2015 Pioneer ... remains at the forefront of designing with reclaimed wood, ... Design in Los Angeles, California. Their newest offerings, Vat ... bring much-anticipated surface and color to America's largest design ... our exhibit at each show, anxious to see and ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Mountain Point Medical ... a ribbon cutting ceremony on Friday, May 29, 2015 at ... to 6 p.m. The new medical center, set to officially ... Triumph Boulevard, Lehi, UT 84043. , “The opening of ... team and the Utah County community,” said Kent Loosle, CEO ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2
... a healthy weight and who have lower perceived stress ... with aging than obese and stressed women, according to ... Study. The long-term Sister Study is looking at the ... breast cancer to identify factors associated with developing breast ...
... unemployed, can attend a local seminar or talk to ... nation marks National Cover the Uninsured Week from March ... Pennsylvanians without health insurance understand their coverage options. A ... the uninsured ranks in Pennsylvania have risen to one ...
... the medications as directed is key, however, experts say, ... one decade, new asthma medications and tools have significantly ... When compared to children treated in the mid-,90s, children ... likely to need oral steroids and rescue inhalers, and ...
... be IncludedPARSIPPANY, N.J., March 16 alli announced today ... new album, Sing , will be given to ... 170-count refill packs in celebration of the brand,s new ... her first album in five years. Hitting retail shelves ...
... or ruling out Alzheimer,s disease has been validated and ... of Medicine. By measuring cerebrospinal fluid (CSF) concentrations of ... peptide and tau protein the test also predicted ... Alzheimer,s disease over time. Researchers were able to detect ...
... 16 The following is being released by the ... conference, "Waste Not, Want Not: The Right Care for ... provide care that not only costs less but is ... patient advocates and other stakeholders to discuss ways to ...
Cached Medicine News:Health News:First sister study results reinforce the importance of healthy living 2Health News:First sister study results reinforce the importance of healthy living 3Health News:Highmark Offers Resources to Help Pennsylvanians Without Health Insurance During Cover the Uninsured Week 2Health News:Highmark Offers Resources to Help Pennsylvanians Without Health Insurance During Cover the Uninsured Week 3Health News:New Treatments Improve Control for Severe Asthma 2Health News:New Treatments Improve Control for Severe Asthma 3Health News:alli Offers New Wynonna Judd Album in Product Packs 2Health News:alli Offers New Wynonna Judd Album in Product Packs 3Health News:Penn Medicine pathologists pioneer biomarker test to diagnose or rule out Alzheimer's disease 2Health News:Penn Medicine pathologists pioneer biomarker test to diagnose or rule out Alzheimer's disease 3Health News:Cleveland Conference: Quality Healthcare Can and Should Cost Less 2Health News:Cleveland Conference: Quality Healthcare Can and Should Cost Less 3Health News:Cleveland Conference: Quality Healthcare Can and Should Cost Less 4Health News:Cleveland Conference: Quality Healthcare Can and Should Cost Less 5
The convenience of safe and precise Patient Controlled Analgesia in a flexible system designed with advanced technology. This is progressive, innovative, and effective pain management in a sophistica...
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology....
... to the Division of Pathology and Laboratory ... the nation's largest and most comprehensive academic ... nearly 700 employees and more than 40 ... 7 million laboratory test results, interpretations and ...
Millenova Immunology Laboratories is a reference laboratory dedicated to the diagnosis of immunologic causes of reproductive failure, infertility and recurrent pregnancy loss....
Medicine Products: